Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and ... Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for ...
Sunday, November 13, 2011
Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for ...
Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and ... Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment